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Abstract- This paper aims to review biomaterials used in 
manufacturing bone plates including advances in recent years 
and prospect in the future. It has found among all biomaterials, 
currently titanium and stainless steel alloys are the most common 
in production of bone plates. Other biomaterials such as Mg 
alloys, Ta alloys, SMAs, carbon fiber composites and bioceramics 
are potentially suitable for bone plates because of their 
advantages in biocompatibility, bioactivity and biodegradability. 
However, today either they are not used in bone plates or have 
limited applications in only some flexible small-size implants. 
This problem is mainly related to their poor mechanical 
properties. Additionally, production processes play an effective 
role. Therefore, in the future, further studies should be 
conducted to solve these problems and make them feasible for 
heavy-duty bone plates.  
Keywords: Biomaterial; Orthopedic bone plate; fracture fixation; 
Biometals; Biocopmosites; Bioceramics; Inert; Bioactive; 
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I. INTRODUCTION 
Origins of biomaterials date back thousands of years, as 
archaeologists have found that metal dental implants have been 
used in 200 A.D. However they have been developed 
significantly after World War II [1]. Today, biomaterials are 
defined as “artificial or natural materials used in the 
manufacturing structures for replacing the lost or diseased 
biological structure to restore its form and function” [2]. A 
biomaterial can exhibit specific interactions with cells that will 
lead to stereotyped response [3]. Performance of biomaterials is 
controlled by two characteristics of biofunctionality and 
biocompatibility [2, 4, 5]. Biofunctionality defines the ability 
of the device to perform the required function and refers to 
mechanical properties of the biomaterial, whereas 
biocompatibility determines the compatibility of the material 
with the body [6]. The use of particular biomaterial for a 
specific application depends on various factors. For instance, 
osteoinduction, osteoconduction angiogenesis, growth rate of 
cells, and degradation rate of the biomaterials in case of 
temporary scaffolds [3]. Biomaterials can be classified as 
organic if they contain carbon, or inorganic if they do not. In 
parallel, they are classified into bioinert, bioactive and 
biodegradable, and materials with possibility of bimolecular 
incorporation as well [5, 7]. Inert biomaterials decrease the 
potential for negative immune response to the implant, while 
bioactive materials interact in a positive manner with the body 
to promote localized healing [1]. Although biodegradable 
materials are the latest advance, the other two generations are 
used widely in manufacturing orthopedic devices including 
bone plates. While Navarro et al [5] had an excellent review on 
biomaterials in orthopaedics in 2008, this paper aims to  have a 
comprehensive review on developments and future advances in 
biomaterials for bone plates. Biomechanical properties of bone 
will be discussed at first. 
II. BIOMECHANICAL PROPERTIES OF BONE 
Biomechanical definition of bone fragility includes at least 
three components of strength, brittleness and work to failure 
[8], which are determined by the concepts of yield strength, 
Ultimate tensile/compression strength and toughness. 
Orthopedic implants must reinforce the fractured-bone from 
these points of view. Yield point (Figure 1) defines the point of 
transition of a material’s behavior from elastic to plastic state 
[9]. Yield strength is known as the required stress to produce a 
very slight amount of plastic strain. Any stress less than yield 
strength causes an elastic deformation, which is recovered after 
removing the load. If loading produces higher stress than yield 
strength, it will cause plastic deformation, which deforms the 
implant permanently. If the stress rises to ultimate strength, 
bone (or implant) will break. 
 
Figure 1 Schematic stress strain curve of bone and biometals 
Modulus of elasticity, E, is the ratio of stress to strain in 
elastic state. Materials with high modulus of elasticity resist 
stress and hold their shape better. Stiffness, the resistance of 
structure against bending, is in direct relation with modulus of 
elasticity. Excessive stiffness of implant induces problems in 
stress shielding of bone during healing [10]. Biomechanical 
properties of selected biomaterials are given in Table 1 for 
comparison. 
Table 1.Biomechanical properties of selected biomaterials [11] 
Biomaterial Ultimate strength (MPa) 
Modulus of 
Elasticity (GPa) 
Elongation 
(%) 
Stainless Steel 580 195 50 
Co-Cr Alloy 
(Wrought) 
793-1000 220 10 
Ti Alloy 900 110 14 
Ceramic 300 350 <2 
Cortical bone 100-150 10-15 1-3 
Trabecular bone 8-50  2-4 
 
According to the table, some of biomaterials break without 
significant deformation. Brittle materials such as glass and 
ceramics absorb relatively little energy before fracture. 
Although depending on the age, bone can be brittle or ductile 
[11], in compare with other biomaterials it shows brittle 
behavior. Role of orthopedic bone plate and screws is to hold 
the fractured bone segments in position, without allowing 
tensile stresses at the fractured interface, but rather have some 
critical compressive stress induced in it so as to accelerate 
healing [10]. Then, neither very low, nor very high magnitudes 
in biomechanical properties of bone plates are proffered. 
Ideally bone plate must have similar biomechanical properties 
to bone to guarantee its biofunctionality.  
III. BIOMETALS 
Biometals used in orthopedics are inorganic metallic 
biomaterials [1]. Biometals used in bone plate are neither 
bioactive [3, 5] nor biodegradable. However, they are the most 
common biomaterials for manufacturing medical devices such 
as hip joints, bone plates and dental implants [12]. Among 
biometals, stainless steel, cobalt alloys and titanium alloys have 
the most applications in orthopedics. 
A. Stainless steel 
Stainless steel, which was first used in orthopedic implants 
in 1920s [13], is the most common biomaterial in 
manufacturing bone plates because of its advantages in 
mechanical strength, cost, manufacturing implants, and 
deformation of implant during surgery [12]. While several 
types of stainless steels are available for use in orthopedics, in 
practice Stainless steel AISI 316L (ASTM F138 & F139) has 
the most biomedical applications due to its better fatigue 
strength, more ductility and better machinability [14]. 
However, it contains Nickel which has a potential of toxicity, 
sensitization and making allergy [15]. Therefore, Ni-free 
stainless steels have been recently developed for use in 
orthopedic field [16-19]. In general, despite having less than 
0.03% (wt, %) carbon to reduce the possibility of in vivo 
corrosion [20], Ti and Co-Cr alloys show better corrosion 
properties [3, 5] and therefore stainless steel is suitable in 
temporary implant devices such as fracture plates, screws and 
hip nails [14]. A temporary implant is expected to provide 
support and assist in cell/tissue growth until the tissue/cell 
regains original shape and strengths [3].  
B. Cobalt-Chromium Alloys 
ASTM has recommended four types of cobalt-chromium 
(Co-Cr) alloys for surgical implant applications including cast 
Co-Cr-Mo alloy (F75), wrought Co-Cr-W-Ni alloy (F90), 
wrought Co-Ni-Cr-Mo alloy (F562) and wrought Co-Ni-Cr-
Mo-W-Fe alloy (F563) [21]. While in all highly alloyed metals 
in body environment, galvanic corrosion can occur, cobalt 
based alloys are highly resistant to corrosion [5] and especially 
to attack by chloride within crevices [22]. Although cobalt 
based alloys are highly resistant to fatigue and cracking caused 
by corrosion they may fail because of fatigue fracture. Of 
course its probability is less than stainless steel stems [22]. In 
vitro studies [21] have indicated that some types of Co alloys 
are toxic to human while other types are well tolerated by cells. 
It is also observed  that cobalt alloys have lower 
biocompatibility and higher mechanical resistance compared 
with titanium alloys [16, 23]. In general, poor fabricability and 
high costs mean that Co-based alloys are currently unsuitable 
for broad use in bone plates [23]. 
C. Titanium alloys 
Attempts to use titanium for manufacturing implants date to 
late 1930s and has been industrially used since 1950s [2]. 
Mechanical properties of implants are made by commercially 
pure titanium (cpTi) mostly depend on manufacturing method 
and amount of trace elements present. Also, apart from low 
mechanical strength, porous coated titanium alloy implants 
show 50-75% lower fatigue strength in compare with the 
equivalent fully dense materials [24]. Only four grades of cpTi 
are distinguished for medical applications (ISO 5832-2) 
depending on the amount of nitrogen, carbon, hydrogen, iron 
and oxygen (ISO 5832-2) [23]. However, cpTi (ASTM F67) 
and Ti-6Al-4V ELI alloy (ASTM F136) are mainly used for 
biomedical applications [20]. 
The strength of cpTi is insufficient and the metals of 
vanadium (V) and Aluminum (Al) in Ti-6Al-4V ELI alloy 
have been identified as harmful elements. So Ti alloys without 
any harmful elements are recently developed [25]. 
Furthermore, other studies are conducted to improve the wear 
resistance of Ti-based materials [2]. In this way, the alloys of 
Titanium and Zirconium have been advised because of good 
responses in terms of biofunctionality and biocompatibility 
[26]. 
Shape memory alloys (SMA) possess certain original 
properties, particularly their ability to return to their memorized 
shape by a simple change of temperature [26]. SMAs have 
been considered for medical applications because of their 
capabilities of recovering the original shape after large 
deformations induced by mechanical load and maintaining the 
deformed shape up to heat induced recovery of the original 
shape [27]. In spite of disadvantages of nickel, Ni-Ti (Nitinol) 
[4, 27, 28] and Ti-Ni-Ag [29] alloys have been mainly studied  
for orthopedics and it has been shown that it does not make 
toxicity and sensitization problems [29]. 
Despite all shortcomings of Ti alloys, its advantages over 
stainless steel and probably over Co-Cr alloys, industrially 
available biomaterials, is remarkable. As they usually provide 
stable internal fixation and reduces the structural weakness of 
the bone during the remodeling phase [30]. Also, using Ti 
alloys accurate radiological assessment of union can determine 
the ideal time for plate removal. Karischak et al. [12] 
demonstrated that cpTi should be treated as the preferred 
material for fracture fixation if a removal of the implant is not 
intended. However, in spite of combining a range of excellent 
properties such as mechanical properties, corrosion resistance, 
fatigue-corrosion resistance, low-density and relatively low 
modulus, Ti and its alloys cannot be recommended as the 
“golden standard” for fracture fixation because of foreign-body 
reaction in local tissues and poor processing capabilities where 
it is machining, forging or heat treating [5, 12]. In general, Ti 
alloys have been advised  as the best available biomaterial for 
bone plate fabrication [31]. Outstanding properties of titanium 
and its alloys make them the biomaterials of preference. 
Additionally its coating possibility with layers of bioactive 
ceramics induces specific reactions of the biological system 
and improves its biocompatibility and bioactivity for 
permanent implantation. 
D. Other biometals 
Several other metals have been studied for a variety of 
specialized implant applications. Tantalum (Ta) is known as an 
excellent biomaterial for bone plates because of excellent 
ductility, toughness, corrosion resistance, biocompatibility, 
bioactivity, cellular adherence, growth and differentiation with 
abundant extracellular matrix formation [24]. However, it has 
limited applications because of processing challenges [24], 
poor mechanical properties and high density [21]. 
Platinum group metals (PGM) such as Platinum (Pt), 
Palladium (Pd), Rhodium (Rh), Iridium (Ir), Ruthenium (Ru), 
and Osmium (Os) are extremely corrosion resistant, but have 
poor mechanical properties [21]. Therefore, currently they are 
not feasible for bone plate. 
Among biodegradable metallic materials magnesium has 
attracted the greatest interest [32, 33]. Magnesium is non-toxic 
to the human body and its excessive amounts can be readily 
excreted by the kidneys. Magnesium is also very important for 
biological functions of the human body [32]. Main 
disadvantage of most magnesium alloys is that they corrode too 
rapidly in physiological environments which produce hydrogen 
pockets near the implant and retard the healing process. Studies 
on Mg–Zn alloys [32, 34, 35] highlights that they have high 
tensile strength and have no adverse effect because of the zinc 
released. Similarly studies on Mg-Zn-Ca [34], Mg-Y-Zn [32, 
36], Mg–Ca [34], Mg-Dy [37] acknowledge their high potential 
for using in fabrication of internal fixation implants.  
IV. POLYMERS AND BIOCOMPOSITES 
Biometals not only are mostly unresorbable but also they 
can cause toxicity by accumulation of metal ions due to 
corrosion. They also also can lead to premature failure due to 
heterogeneous stress distribution, which is caused by higher 
elastic modulus of the implant compared with bone [5]. 
Therefore, in parallel with studies on biometals, numerous 
studies [3, 5, 7, 38-40] have been conducted on organic 
biomaterials and biocomposites. Their better biocompatibility 
and biodegradation have encouraged the scientists as well. 
Polymethyl-methacrylate (PMMA), Poly lactic acid (PLA), 
Poly glycolic acid (PGA), L-PLA (PLLA), D-PLA (PDLA), 
Polyglycolic acid (PGA), Polycaprolactone (PCL), 
Polyhydroxybutyrate (PHB), poly ether–ether-ketone (PEEK), 
Poly(2-hydroxy-ethyl-methacrylate) (PHEMA), and 
Polydioxanone (PDS) have widely been studied for orthopedic 
applications such as bone substitution, bone fracture fixation 
and cartilage [5, 7]. While these studies show that the 
orthopedic implants of biocomposites and biopolymers can be 
used instead of metallic ones, in practice they only have limited 
application in dental implants and also in small flexible internal 
fixators [41]. Their poor mechanical properties has been 
introduced as the main reason [5] for preventing their wide 
application in orthopedics. 
Studies on development of carbon fiber-reinforced-epoxy-
resin for use in bone plates were started in early 1970s [42]. 
Examination of similar-shape Plates from fiber-polymer 
composites and available metal materials in dogs [43] revealed 
that these plates show similar results in long-term. Generally, 
Studies on biocomposites  [5, 42-44] show that the mechanical 
properties of the plate manufactured by biocomposites is 
comparable with biometals and biodegradable polymers should 
be highly considered in design of new plates. Finite element 
studies acknowledge these results [7, 38, 44, 45]. Shikinami et 
al [46-49] conducted a series of studies on substitution of 
forged composites of unsintered HA particles and HA/PLLA 
instead of available metallic plates. They reinforced the 
composite by forging and then machined on a lathe to produce 
internal bone fixation devices. Measuring various mechanical 
properties they concluded that the studied composites give 
superior properties in density, strength, biocompatibility and 
processing capabilities in compare with current biomaterials. 
Therefore, many kinds of fine and accurate screws, pins, plates, 
and other internal bone fixation devices for orthopedic, oral 
and maxillofacial, craniofacial, and reconstructive surgeries 
can be produced from them. Comparing different 
compositions, they also conclude that the F-u-HA30/40 
composites containing 30wt%/40wt% u-HA particles are 
clinically effective for use in high-strength bioactive, bio-
resorbable bone-fixation devices with the capacity for total 
bone replacement. 
Studies on partially resorbable composite bone plate 
consisting of PLLA and textile Bioglass fibers [50] indicated 
that this plate system is suitable for forearm region and it is 
capable of reducing stress shielding effects at the fracture site. 
Similar studies on compression bone plates of Carbon/PEEK 
composite material [51] provide similar results. In other studies 
[10, 52, 53], non-homogenous stiffness graded (SG) plates 
were compared with a homogenous stainless steel plate on 
stress shielding  and the effectiveness of SG plate rather than a 
homogenous stainless steel plate for was demonstrated. 
According to findings, stress shielding in bone SG plate is less 
compared to Stainless Steel plate [52]. Since SG plates are 
more flexible, they permit more bending of the fractured bone, 
higher compressive stress at the fractured interface which 
induces accelerated healing and higher tensile stress in the 
intact portion of the bone [10]. Others [54-56] studied the 
healing efficiency of flexible Kevlar1/BCP (biphasic calcium 
phosphate) composite bone plates applied to a tibia and showed 
that the composite plates generate the most appropriate strain 
distributions at the fracture site during early healing process. It 
provides higher healing rates compared to conventional steel 
                                                            
1 Kevlar is a registered trade mark of Du Pont 
plates, and improves callus generation at the fracture site. It 
also reduces the contact stress at the contact area. 
With thorough literature review, Ramakrishna et al [41] 
concluded that for greater success in application of polymer 
and composite biomaterials in orthopedic implants, they should 
be surface compatible as well as structurally compatible with 
the host tissue. Additionally, due to lack of the experimental 
and clinical supporting data, further studies should be 
conducted to elucidate the long-term durability of these 
biomaterials in human body conditions. Also, surgeons must be 
convinced about the long-term durability and reliability of 
polymer and composite biomaterials. 
V. BIOCERAMICS 
Bioceramics are classified in inorganic biomaterials. 
Bioactive ceramics such as Alumina [57, 58], Zirconia [58, 59], 
Yttria-stabilized Zirconia (Y-TZP) [58],  (HA) and Hydroxy 
Carbonate Apatite (HCA) [17, 19, 46-49, 60], tricalcium 
phosphate (TCP) [58, 61], Bioglass® (BG) [62, 63], and glass-
ceramic (A-W G-C2) [62, 64] have been studied for orthopedic 
applications. Regarding the results, due to their low tensile 
strength and lower fracture toughness in compare with human 
cortical bone they cannot be used independently as bone 
substitute or bone plate for high load bearing joint [24]. This 
problem is more serious for highly porous ceramics. Despite 
promotion of bone in growth and induce prosthesis 
stabilization they cannot be used in load bearing applications 
[5]. As a solution bioceramics are usually used as coatings  of 
other bioinert materials such as titanium alloys [62]. Among 
the bioceramics calcium phosphate biomaterials (mainly HA 
and TCP) are the most popular because of their close properties 
to the bone [58]. However, they have serious shortcomings 
such as  delamination, and decomposition in long-term 
implementation [24], micro and macro porosities which affect 
on biological properties, low crack resistance and toughness 
[58] which limits their applications in coatings. Y-TZP has the 
best toughness and strength among current bioceramics; 
however it is not stable in long term implementation [58] and 
therefore cannot be used in permanent implants. In general, 
bioceramics are not suitable for bone plates unless for coating 
or composition with other biomaterials. Future studies should 
solve their drawbacks such as delamination and 
decompositions if they are used as coating. 
 
VI. CONCLUSION 
Biomaterials play a prominent role in efficiency of bone 
plates because of their direct and indirect effects on healing 
process, and therefore numerous studies have been conducted 
in this field. As a result, biomaterials used in manufacturing 
bone plates have been significantly improved and their 
approach has been totally changed from bioinert stabilizers to 
bioactive and biodegradable healing facilitators. Also, many 
investigations have been performed to maximize their 
biocompatibility, bioactivity, biodegradability, and cellular 
interaction. However, currently specific classes of stainless 
steel and titanium alloys are mainly used in practice. 
Additionally: 
                                                            
2 Apatite-wollastonite Glass-ceramic 
 Ideal biomaterial for bone plate should have high 
corrosion resistance, wear resistance, strength, 
biocompatibility, bioactivity, and biodegradability (if it 
is not used for permanent application). It also should 
have close mechanical properties to bone specially 
Young’s modulus. Furthermore, it should not make 
toxicity, allergy and sensitivity. 
 Micro and nano scale properties of biomaterials and 
their cellular interactions play significant role in their 
performance and therefore they should be considered 
in future studies. Also, multi-disciplinary studies 
including biology, material science, chemistry and 
mechanics should be conducted in developing 
biomaterials to improve both characters of 
biofunctionality and biocompatibility. 
 Manufacturing techniques directly affect 
biofunctionality of the bone plates and then they 
should be considered more in future studies. 
 In some circumstances it is necessary to use permanent 
implant for treatment. Unresorbable, biocompatible 
and bioactive biomaterials should be used in these 
cases. Otherwise biodegradable biomaterials are 
preferred. 
 Magnesium and tantalum alloys are potentially very 
good biometals because of their bioactivity, 
biocompatibility, and biodegradability. However, they 
have significant shortcomings in mechanical properties 
and production process. Further studies should be 
conducted to solve these problems. 
 Polymers and biocomposites have many advantages to 
current biomaterials because of biodegradability, better 
biocompatibility, and higher bioactivity. However they 
have only limited implementation in small-size flexible 
implants. Further studies should be conducted to 
improve their biomechanics to enable them to be used 
in heavy-duty bone plates. 
 Although bioceramics are bioactive and biocompatible, 
they cannot be used independently in bone plates, 
which usually involves with loading. Despite having 
high potential for use as coating of inert biometals, 
they have some serious drawbacks such as cracks, 
porosities and delamination. Further studies should be 
conducted to solve these problems. After solving these 
problems they can be used as a suitable coating of bone 
plates. 
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